Early prediction of cerebral-cardiac syndrome after ischemic stroke: the PANSCAN scale

Haijuan Lian1,2,3, Xiaomeng Xu4, Xuhui Shen3

  • 1Hangzhou Medical College, Hangzhou, 310053, China.

BMC Neurology
|July 10, 2020
PubMed

Insights

A new PANSCAN score effectively identifies patients with ischemic stroke at high risk of developing cerebral-cardiac syndrome (CCS). This tool aids in early management and preventative treatment for stroke patients.

Area of Science:

  • Neurology
  • Cardiology
  • Medical Informatics

Background:

  • Cerebral-cardiac syndrome (CCS) is a complication of stroke, increasing morbidity and mortality.
  • Early identification of high-risk individuals is crucial for timely intervention.

Purpose of the Study:

  • To develop and validate a risk prediction scale for cerebral-cardiac syndrome in ischemic stroke patients.
  • To stratify high-risk populations for targeted preventative strategies.

Main Methods:

  • Logistic regression analysis was used to establish a predictive model from a derivation cohort (250 patients).
  • External validation was performed on a separate cohort (160 patients).
  • The PANSCAN score was developed based on independent risk factors identified by regression coefficients.

Main Results:

  • The prevalence of CCS was 55.2% in the study population.
  • The PANSCAN score, ranging from 0 to 10 points, incorporates factors like PT, APTT, neutrophils, sex, carotid artery stenosis, age, and NIHSS score.
  • A score of 3 or more points stratified patients as high-risk, with good model performance (C-statistics: 0.888 derivation, 0.813 validation).

Conclusions:

  • The developed risk prediction model demonstrates satisfactory predictive performance for CCS in ischemic stroke.
  • The PANSCAN scale offers a practical tool for preventative treatment and early management of high-risk patients.
Abstract